CEL-SCI Corporation (NYSEAMEX:CVM) stock gained 6.53% to $0.302. The company on April 23 provided an

Austin, TX -- ( SBWIRE ) -- 04/25/2013 -- Jackpotpennystocks.com , an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, hotels a barcelona issues news updates on the following stock:-
TriQuint Semiconductor (NASDAQ:TQNT) shares gained 9.67% to $5.34. The company on April 24 reported first-quarter net loss of $27.9 million or $0.17 per share, compared to net income hotels a barcelona of $1.9 million or $0.01 per share last year. Revenues hotels a barcelona for the quarter dropped to $184.2 million from $216.7 million last year. Analysts estimated loss of $0.12 per share on revenues of $186.39 million for the quarter.
Royal Caribbean Cruises Ltd.(NYSE:RCL) shares hotels a barcelona gained 7.35% and closed at $36.81. The company, on April 25, reported that its first-quarter hotels a barcelona net income rose to $76.23 million or $0.35 per share, from $46.96 million or $0.21 per share last year. Total revenues increased to $1.91 billion, from $1.84 billion last year. Analysts expected the company to report profit of $0.21 per share on revenue of $1.86 billion for the quarter.
Lam Research Corporation (NASDAQ:LRCX) shares gained 6.51% to $45.83. The company on April 24 company reported third quarter net income of $19 million or $0.11 per share, sharply down from $45.6 million or $0.38 per share last year. Adjusted earnings for the quarter were $74.5 million or $0.44 per share. Analysts estimated earnings of $0.37 per share for the quarter. Revenues for the quarter were $845 million, compared to $656 million a year ago. Analysts on consensus hotels a barcelona estimated revenues of $838.33 million hotels a barcelona for the quarter.
CEL-SCI Corporation (NYSEAMEX:CVM) stock gained 6.53% to $0.302. The company on April 23 provided an update on the Phase III Clinical Trial of its investigational drug Multikine* (Leukocyte Interleukin, Injection) for the treatment of head and neck cancer. The Company announced that it has hired two clinical research organizations (CRO's) who will manage the global Phase III study; Aptiv Solutions and Ergomed who are both international leaders in managing oncology trials.
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis hotels a barcelona of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, hotels a barcelona investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. hotels a barcelona Jackpotpennystocks.com hotels a barcelona does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.